spineicon.jpg (4507 bytes)
Interventional Neuroradiology     MGH  Neurosurgical Service Home Brain Tumor Center MGH Cancer Center Dana Farber CancerCare
Interventional Neuroradiology
MGHHvd Med School
[Divider]
Spine / Spinal Cord Tumor Clinic at MGHNeurosurgery at MGHOrthopaedic Soine Surgert at MGHRadiation Oncology at MGHNeuro-Oncology at MGHBrain Tumor Center at MGH
[Divider]

Research

The laboratory and clinical research programs at the MGH Brain Tumor Center and Spine Tumor Clinic represent a broad, in-depth effort aimed at identifying improved treatments for all types of brain tumors.

The STC and BTC work in partnership with the MGH Molecular Neuro-Oncology Laboratory to create a remarkably strong resource for advances in the treatment of all brain and spine tumors. Scientists at the Centers seek to understand the molecular and genetic mechanisms that cause tumors to form and grow within the brain, spine and spinal cord.

[Divider]

Select Publications:

The Brian D. Silber Memorial Fund has supported the research published in the following journal articles [see Publications for the Abstracts and links to PubMed searches of current/past publications from the STC Staff]:

Chakravarti, A.; Chakladar, A.; Delaney, M.A.; Latham, D.E.; Loeffler, J.S. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res. 2002; 62(15):4307-4315. [download pdf reprint of publication]

Chakravarti, A.; Noll, E.; Black, P.B.; Dyson, N.J.; Loeffler, J.S. Quantitatively-determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol. 20(4):1063-1068, 2002. [download pdf reprint of publication]

Chakravarti, A.; Loeffler, J. S.; Dyson, N..J. Insulin-like growth factor receptor I (IGFRI) mediates resistance to anti-epidermal growth factor receptor (EGFR) therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res. 62(1):200-207, 2002. [download pdf reprint of publication]

Chakravarti, A.; Delaney, M.D.; Noll, E.; Loeffler, J.S.; Black, P.B.; Dyson, N.J. Prognostic and pathologic significance of protein expression profiling in human gliomas. Clinical Cancer Research 7:2387-2395, 2001. [download pdf reprint of publication]

Henson, John W. Spinal cord gliomas. Curr Opin Neurol 2001 Dec;14(6):679-82. [download MS WordTM version]

Henson, J.W.; Thornton,A.F.; and Louis, D.N. Spinal cord astrocytoma: Response to PCV chemotherapy. Neurology 2000 Jan 25;54(2):518-20. [download MS WordTM version]

[Divider]

STC Services Your Treatment Team Conferences Education Research Publications In the News Neurosurgery BTC Links Search

Disclaimer About Medical Information: The information and reference materials contained herein is intended solely for the information of the reader. It should not be used for treatment purposes, but rather for discussion with the patient's own physician. All visitors to this and associated sites from the Neurosurgical Service at MGH agree to read and abide by the the complete terms of legal agreement found at the Neurosurgery "disclaimer & legal agreement." See also: the MGH Disclaimer, the MGH Privacy Policy, and the MGH Interactive Program Disclaimer - © Copyright 2000.
[Divider]
electronswebs
MGH  Neurosurgical Service Home
Research@NeurosurgeryVisitors must read the disclaimer - legal agreement.
© All Rights Reserved. Copyright © 2000 MGH Neurosurgical Service
MGH NeuroCare Info Systems
NeuroCare
(internal access only)
System Info Contact: WebServant or the PageServant or e-mail C.Owen
Last modified:March 7, 2007
Referral@Neurosurgery.MassGeneral.org